DNA Synthesis News and Research

RSS

Neurons re-entering cell cycle succumb to senescence in neurodegenerative diseases

Post-mitotic neurons in the brain that re-enter the cell cycle quickly succumb to senescence, and this re-entry is more common in Alzheimer's disease, according to a new study published April 9th in the open-access journal PLOS Biology by Kim Hai-Man Chow and colleagues at the Chinese University of Hong Kong.

23 Apr 2024

New interdisciplinary center aims to spark developments in synthetic genomics

Applying and developing new technologies for DNA synthesis to pave the way for producing entire artificial genomes - that is the goal of a new interdisciplinary center that is being established at Heidelberg University, Karlsruhe Institute of Technology (KIT), and Johannes Gutenberg University Mainz (JGU). The aim of the Center for Synthetic Genomics is to spark new developments in synthetic genomics through basic research and technology development using methods of artificial intelligence.

6 Mar 2024

Mutations found in skin cancers could be harnessed to mend broken hearts

Biomedical engineers at Duke University have demonstrated that one of the most dangerous mutations found in skin cancers might moonlight as a pathway to mending a broken heart.

24 Jan 2024

Evonetix Announces Agreement for Revolutionary Gene Synthesis Platform With Analog Devices

EVONETIX LTD (‘Evonetix’), the company developing semiconductor scale technology to improve access to gene synthesis, today announces the signing of a joint development agreement and commercial supply agreement with Analog Devices, Inc. (ADI), a global semiconductor leader.

6 Dec 2023

Camena Bioscience appoints Dr. Nicola Thompson as Chair of the Board

Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, today announced it has appointed Dr Nicola Thompson as Chair of its Board of Directors.

From Camena Bioscience 6 Dec 2023

Synthetic biologists develop versatile platform for targeted drug delivery

In recent years, cell and gene therapies have shown significant promise for treating cancer, cystic fibrosis, diabetes, heart disease, HIV/AIDS and other difficult-to-treat diseases.

27 Nov 2023

Scientists unravel secrets about the formation of DNA's building blocks

An international team has uncovered details about the formation of DNA's building blocks, paving the way for potential medical and therapeutic applications.

12 Oct 2023

Gut health and leukemia: Exploring the crucial connection between diet and microbiota changes

Gut microbiota's role in leukemia treatment responses is explored, with evidence suggesting diet and prebiotics may help manage microbiota alterations in patients. Diet during pregnancy, breastfeeding, and gut microbiota composition all intersect, potentially influencing leukemia risks and treatment outcomes.

8 Oct 2023

Evonetix unveils new branding to align with its vision for gene-length DNA synthesis

EVONETIX LTD (‘Evonetix’) today announces the introduction of new branding.

From Evonetix 2 Oct 2023

A hybrid approach to re-engineer a SARS-CoV-1 neutralizing antibody against SARS-CoV-2

A hybrid approach involving a combination of conventional discovery and antibody repurposing to combat COVID-19.

21 Aug 2023

Living digital camera: scientists capture light patterns in DNA for image storage

Researchers described a technique of capturing two-dimensional (2D) light patterns into DNA.

6 Jul 2023

Camena Bioscience closes $10m Series A financing as demand for DNA synthesis technology increases

Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries.

From Camena Bioscience 3 Jul 2023

Regulatory connection between DREAM and cellular senescence may play a potential role in aging process

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 10, entitled, "Key elements of cellular senescence involve transcriptional repression of mitotic and DNA repair genes through the p53-p16/RB-E2F-DREAM complex."

13 Jun 2023

Evonetix delivers first chip-synthesized DNA to the University of Cambridge

Evonetix, the company bringing semiconductor technology to DNA synthesis, today announced that DNA synthesized using its unique semiconductor chip technology was delivered to the Department of Chemical Engineering and Biotechnology at the University of Cambridge.

From Evonetix 10 May 2023

DNA Synthesis News and Research

Neurons re-entering cell cycle succumb to senescence in neurodegenerative diseases

New interdisciplinary center aims to spark developments in synthetic genomics

Mutations found in skin cancers could be harnessed to mend broken hearts

Evonetix Announces Agreement for Revolutionary Gene Synthesis Platform With Analog Devices

Camena Bioscience appoints Dr. Nicola Thompson as Chair of the Board

Synthetic biologists develop versatile platform for targeted drug delivery

Scientists unravel secrets about the formation of DNA's building blocks

Gut health and leukemia: Exploring the crucial connection between diet and microbiota changes

Evonetix unveils new branding to align with its vision for gene-length DNA synthesis

A hybrid approach to re-engineer a SARS-CoV-1 neutralizing antibody against SARS-CoV-2

Living digital camera: scientists capture light patterns in DNA for image storage

Camena Bioscience closes $10m Series A financing as demand for DNA synthesis technology increases

Regulatory connection between DREAM and cellular senescence may play a potential role in aging process

Evonetix delivers first chip-synthesized DNA to the University of Cambridge

CRISPR-Cas9 system can help reduce adenovirus replication in human cells

One-Pot-LAMP: A promising tool for non-small cell lung cancer diagnosis

Study shows SARS-CoV-2 causes DNA damage and elicits an altered DNA damage response

Evonetix closes $24 million USD (£20 million) financing

Study uncovers protein that acts as a brake for DNA replication

Generative AI approach unlocks path to accelerated antibody drug creation for novel therapeutic targets

Biochemistry eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News